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Clinical PerspectiveWhat Is New?We performed a systematic analysis and meta‐analysis of histologically diagnosed cardiac sarcoidosis for patterns of myocardial involvement using gross pathological images from autopsy or cardiac transplantation cases.Certain features of myocardial involvement were seen in \>90% of cases: left ventricular (LV) subepicardial, LV multifocal, septal, and right ventricular free wall involvement.Other patterns were seen in 0% to 6% of cases: absence of gross myocardial involvement, isolated LV midmyocardial involvement, isolated LV subendocardial involvement, isolated LV transmural involvement, absence of septal involvement, or isolated involvement of only one LV level.What Are the Clinical Implications?These patterns of myocardial involvement in cardiac sarcoidosis could aid the interpretation of cardiovascular magnetic resonance imaging and ^18^F‐fluorodeoxyglucose positron emission tomography imaging and improve the diagnosis and the prognostication of patients with suspected cardiac sarcoidosis.

Introduction {#jah34071-sec-0008}
============

Sarcoidosis is a multisystem granulomatous disorder of unclear cause. The heart is involved in up to 25% of patients with sarcoidosis, and cardiac sarcoidosis is often associated with a poor prognosis.[1](#jah34071-bib-0001){ref-type="ref"} Cardiovascular magnetic resonance imaging (CMR) is frequently used in the evaluation of patients with suspected cardiac sarcoidosis, and myocardial involvement identified as late gadolinium enhancement (LGE) is incorporated in the various diagnostic criteria used to make the diagnosis of cardiac sarcoidosis.[2](#jah34071-bib-0002){ref-type="ref"}, [3](#jah34071-bib-0003){ref-type="ref"}, [4](#jah34071-bib-0004){ref-type="ref"}, [5](#jah34071-bib-0005){ref-type="ref"}, [6](#jah34071-bib-0006){ref-type="ref"} Similarly, ^18^F‐fluorodeoxyglucose (^18^F‐FDG) positron emission tomography is also often used in the evaluation and monitoring of patients with suspected cardiac sarcoidosis, with active myocardial involvement identified as ^18^F‐FDG uptake.[2](#jah34071-bib-0002){ref-type="ref"}, [3](#jah34071-bib-0003){ref-type="ref"}, [4](#jah34071-bib-0004){ref-type="ref"}, [5](#jah34071-bib-0005){ref-type="ref"}, [6](#jah34071-bib-0006){ref-type="ref"}

Patel et al first described diverse patterns of LGE in patients with extracardiac biopsy‐proven sarcoidosis.[7](#jah34071-bib-0007){ref-type="ref"} Although 86% (18/21) of patients with LGE in the study had at least one region with LGE in a nonischemic pattern, subendocardial LGE typical for coronary artery disease was also noted as representing cardiac sarcoidosis in the absence of obstructive coronary artery disease. This study was the basis of statements in the 2014 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Management of Arrhythmias Associated With Cardiac Sarcoidosis that "there is no specific pattern of LGE that is pathognomonic for cardiac sarcoidosis" and "...even a pattern that is typical for prior myocardial infarction can also represent cardiac sarcoidosis."[3](#jah34071-bib-0003){ref-type="ref"} The lack of a specific LGE pattern for cardiac sarcoidosis makes it challenging to make the diagnosis.[8](#jah34071-bib-0008){ref-type="ref"} This is an important issue as patient management is often guided by clinical diagnoses rather than histological diagnoses because an endomyocardial biopsy is deemed to have limited sensitivity to detect cardiac sarcoidosis.[3](#jah34071-bib-0003){ref-type="ref"} Although the presence of frequent LGE patterns in cardiac sarcoidosis has been suggested,[9](#jah34071-bib-0009){ref-type="ref"}, [10](#jah34071-bib-0010){ref-type="ref"} there has been no systematic analysis of patterns of myocardial involvement in cardiac sarcoidosis, especially in histologically diagnosed cardiac sarcoidosis. We hypothesized that certain patterns of myocardial involvement are more frequent in histologically diagnosed cardiac sarcoidosis.

To determine patterns of myocardial involvement in cardiac sarcoidosis, we performed a systematic review and meta‐analysis of published gross pathological images of the heart from patients with histologically diagnosed cardiac sarcoidosis.

Methods {#jah34071-sec-0009}
=======

All data supporting the findings are provided within the article. We studied gross pathological images of hearts from either patients who underwent a autopsy or those who had heart transplantation for cardiac sarcoidosis and had a definitive histological diagnosis of cardiac sarcoidosis. Patients who underwent a autopsy died from either sudden cardiac death attributed to cardiac sarcoidosis or other causes directly related to cardiac sarcoidosis (eg, multiorgan failure after recurrent ventricular arrhythmias attributed to cardiac sarcoidosis). We chose to specifically study these patients because they experienced the major adverse cardiac events that we aim to avoid in patients with suspected cardiac sarcoidosis.

Search Strategy {#jah34071-sec-0010}
---------------

We searched the PubMed, Embase, and Cochrane databases in March 2018 to perform a systematic review of peer‐reviewed publications that included gross pathological images of hearts taken from patients who either died from cardiac sarcoidosis or underwent heart transplantation for cardiac sarcoidosis. Search terms used were as follows: "cardiac sarcoidosis and pathology," "cardiac sarcoidosis and autopsy," "cardiac sarcoidosis and autopsy," and "cardiac sarcoidosis and explant."

Study Selection {#jah34071-sec-0011}
---------------

Two investigators (O.O. and C.S.) independently scanned all titles and abstracts and obtained full‐text reports of articles that indicated or suggested eligibility. The full‐text articles were then assessed for eligible gross heart pathological images by the same investigators independently. We included images from patients who either died of causes related to cardiac sarcoidosis or underwent heart transplantation for cardiac sarcoidosis and had a histological diagnosis of cardiac sarcoidosis based on the presence of noncaseating granulomas. We excluded gross pathological images when the myocardium could not be assessed in at least 6 of 17 American Heart Association left ventricular (LV) segments[11](#jah34071-bib-0011){ref-type="ref"} because of either anatomical sections performed or poor image quality.

Data Collection {#jah34071-sec-0012}
---------------

To identify features of myocardial involvement in patients with cardiac sarcoidosis, 2 investigators (O.O., F.K.) independently recorded the following 5 domains of myocardial damage features from the gross pathological images: Location of involvement within the LV wall:Subepicardial (involvement of the outer portion, including the right ventricular \[RV\] aspect of the interventricular septum);Midmyocardial (involvement of the middle portion);Subendocardial (involvement of the inner portion);Transmural (involvement of the entire thickness of the wall).Focality within the LV:Unifocal (1 single lesion);Multifocal (\>1 discrete lesion).LV segments involved:Anterior segments;Septal segments;Inferior segments;Lateral segment.LV levels involved:Basal LV;Mid LV;Apical LV.Involvement of the RV free wallYes;No.

Discordances were resolved after consensus with a third investigator (C.S.). Within each domain, the prevalence of various features of myocardial involvement was compared. Features that were either frequently (\>90%) or rarely (\<10%) present were identified.

Statistical Analysis {#jah34071-sec-0013}
--------------------

Categorical variables were expressed as counts with percentages. χ^2^ Tests were used to compare discrete data between groups; in those cases in which the expected cell count was \<5, the Fisher exact test was used. Statistical analyses were performed using R, version 3.3.3 (The R Foundation; <https://www.r-project.org/>). All statistical tests were 2 tailed, and *P*\<0.05 was considered statistically significant.

Results {#jah34071-sec-0014}
=======

The systematic review yielded 33 articles[12](#jah34071-bib-0012){ref-type="ref"}, [13](#jah34071-bib-0013){ref-type="ref"}, [14](#jah34071-bib-0014){ref-type="ref"}, [15](#jah34071-bib-0015){ref-type="ref"}, [16](#jah34071-bib-0016){ref-type="ref"}, [17](#jah34071-bib-0017){ref-type="ref"}, [18](#jah34071-bib-0018){ref-type="ref"}, [19](#jah34071-bib-0019){ref-type="ref"}, [20](#jah34071-bib-0020){ref-type="ref"}, [21](#jah34071-bib-0021){ref-type="ref"}, [22](#jah34071-bib-0022){ref-type="ref"}, [23](#jah34071-bib-0023){ref-type="ref"}, [24](#jah34071-bib-0024){ref-type="ref"}, [25](#jah34071-bib-0025){ref-type="ref"}, [26](#jah34071-bib-0026){ref-type="ref"}, [27](#jah34071-bib-0027){ref-type="ref"}, [28](#jah34071-bib-0028){ref-type="ref"}, [29](#jah34071-bib-0029){ref-type="ref"}, [30](#jah34071-bib-0030){ref-type="ref"}, [31](#jah34071-bib-0031){ref-type="ref"}, [32](#jah34071-bib-0032){ref-type="ref"}, [33](#jah34071-bib-0033){ref-type="ref"}, [34](#jah34071-bib-0034){ref-type="ref"}, [35](#jah34071-bib-0035){ref-type="ref"}, [36](#jah34071-bib-0036){ref-type="ref"}, [37](#jah34071-bib-0037){ref-type="ref"}, [38](#jah34071-bib-0038){ref-type="ref"}, [39](#jah34071-bib-0039){ref-type="ref"}, [40](#jah34071-bib-0040){ref-type="ref"}, [41](#jah34071-bib-0041){ref-type="ref"}, [42](#jah34071-bib-0042){ref-type="ref"}, [43](#jah34071-bib-0043){ref-type="ref"}, [44](#jah34071-bib-0044){ref-type="ref"} published in the peer‐reviewed literature between 1974 and March 2018 (Figure [1](#jah34071-fig-0001){ref-type="fig"}). The 33 articles provided gross pathological images of 49 unique hearts with cardiac sarcoidosis: 25 were from autopsy examinations, and 24 were explanted for heart transplantation (Table [1](#jah34071-tbl-0001){ref-type="table"}). All heart transplantations occurred for cardiac sarcoidosis, and of the 25 hearts from autopsy examinations, 18 (72%) had sudden death and 7 (28%) died of immediate causes other than sudden death but cardiac sarcoidosis directly contributed to the death. Five representative examples[17](#jah34071-bib-0017){ref-type="ref"}, [24](#jah34071-bib-0024){ref-type="ref"}, [29](#jah34071-bib-0029){ref-type="ref"}, [39](#jah34071-bib-0039){ref-type="ref"}, [44](#jah34071-bib-0044){ref-type="ref"} with details of features of myocardial involvement are reproduced in Figure [2](#jah34071-fig-0002){ref-type="fig"}. All 49 gross pathological images are reproduced with permission in Figures S1 through S49.

![Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow diagram showing the flow of information through the different phases of the systematic review.](JAH3-8-e011253-g001){#jah34071-fig-0001}

###### 

Articles and Gross Pathological Images of Cardiac Sarcoidosis Included in the Study

  Figure   Article No.   Author and Year of Publication                                       Figure No. Within Article   Autopsy or Explant   Cause of Death         No. of LV Segments Seen
  -------- ------------- -------------------------------------------------------------------- --------------------------- -------------------- ---------------------- -------------------------
  S1       1             Fawcett and Goldberg, 1974[12](#jah34071-bib-0012){ref-type="ref"}   1                           Autopsy              Sudden cardiac death   6
  S2       2             Fleming, 1974[13](#jah34071-bib-0013){ref-type="ref"}                4                           Autopsy              Sudden cardiac death   6
  S3       2             Fleming, 1974[13](#jah34071-bib-0013){ref-type="ref"}                9                           Autopsy              Sudden cardiac death   6
  S4       3             Roberts et al, 1977[14](#jah34071-bib-0014){ref-type="ref"}          5                           Autopsy              Sudden cardiac death   6
  S5       4             James and Pounder, 1982[15](#jah34071-bib-0015){ref-type="ref"}      1                           Autopsy              Sudden cardiac death   6
  S6       5             (Authors not listed), 1990[16](#jah34071-bib-0016){ref-type="ref"}   9                           Autopsy              Cardiogenic shock      6
  S7       6             Antecol and Roberts, 1990[17](#jah34071-bib-0017){ref-type="ref"}    5                           Autopsy              Sudden cardiac death   12
  S8       7             Shirani and Roberts, 1993[18](#jah34071-bib-0018){ref-type="ref"}    4                           Autopsy              Sudden cardiac death   17
  S9       7             Shirani and Roberts, 1993[18](#jah34071-bib-0018){ref-type="ref"}    5                           Autopsy              Sudden cardiac death   6
  S10      8             Donsky et al, 2002[19](#jah34071-bib-0019){ref-type="ref"}           2                           Explant              ...                    17
  S11      9             Wan Muhaizan et al, 2004[20](#jah34071-bib-0020){ref-type="ref"}     2                           Autopsy              Cardiogenic shock      16
  S12      10            Goyal and Aragam, 2006[21](#jah34071-bib-0021){ref-type="ref"}       1                           Explant              ...                    6
  S13      11            Halushka et al, 2006[22](#jah34071-bib-0022){ref-type="ref"}         1                           Explant              ...                    6
  S14      12            Hamilton et al, 2007[23](#jah34071-bib-0023){ref-type="ref"}         1                           Autopsy              Sudden cardiac death   6
  S15      13            Morikawa et al, 2008[24](#jah34071-bib-0024){ref-type="ref"}         2                           Autopsy              Hemorrhagic shock      6
  S16      14            Luk et al, 2009[25](#jah34071-bib-0025){ref-type="ref"}              2                           Explant              ...                    6
  S17      15            Riezzo et al, 2009[26](#jah34071-bib-0026){ref-type="ref"}           2                           Autopsy              Sudden cardiac death   6
  S18      16            Roberts et al, 2009[27](#jah34071-bib-0027){ref-type="ref"}          2                           Explant              ...                    17
  S19      16            Roberts et al, 2009[27](#jah34071-bib-0027){ref-type="ref"}          3                           Explant              ...                    17
  S20      16            Roberts et al, 2009[27](#jah34071-bib-0027){ref-type="ref"}          4                           Explant              ...                    12
  S21      17            Sharma et al, 2009[28](#jah34071-bib-0028){ref-type="ref"}           1, 2                        Autopsy              Sudden cardiac death   17
  S22      18            Tavora et al, 2009[29](#jah34071-bib-0029){ref-type="ref"}           2                           Autopsy              Sudden cardiac death   6
  S23      18            Tavora et al, 2009[29](#jah34071-bib-0029){ref-type="ref"}           2                           Autopsy              Sudden cardiac death   6
  S24      18            Tavora et al, 2009[29](#jah34071-bib-0029){ref-type="ref"}           3                           Autopsy              Sudden cardiac death   17
  S25      18            Tavora et al, 2009[29](#jah34071-bib-0029){ref-type="ref"}           7                           Autopsy              Sudden cardiac death   6
  S26      19            Dubrey and Falk, 2010[30](#jah34071-bib-0030){ref-type="ref"}        2                           Explant              ...                    6
  S27      20            Lagana et al, 2010[31](#jah34071-bib-0031){ref-type="ref"}           1                           Explant              ...                    6
  S28      21            Bagwan et al, 2011[32](#jah34071-bib-0032){ref-type="ref"}           1                           Autopsy              Sudden cardiac death   6
  S29      22            Strauss et al, 2011[33](#jah34071-bib-0033){ref-type="ref"}          2                           Explant              ...                    6
  S30      23            Armstrong, 2013[34](#jah34071-bib-0034){ref-type="ref"}              2                           Autopsy              Sudden cardiac death   6
  S31      24            Zacek et al, 2013[35](#jah34071-bib-0035){ref-type="ref"}            2                           Autopsy              Cardiogenic shock      6
  S32      25            Lynch et al, 2014[36](#jah34071-bib-0036){ref-type="ref"}            1                           Autopsy              Sudden cardiac death   6
  S33      26            Roberts et al, 2014a[37](#jah34071-bib-0037){ref-type="ref"}         1                           Explant              ...                    17
  S34      26            Roberts et al, 2014[37](#jah34071-bib-0037){ref-type="ref"}          2                           Explant              ...                    17
  S35      26            Roberts et al, 2014[37](#jah34071-bib-0037){ref-type="ref"}          3                           Explant              ...                    17
  S36      26            Roberts et al, 2014[37](#jah34071-bib-0037){ref-type="ref"}          4                           Explant              ...                    17
  S37      26            Roberts et al, 2014[37](#jah34071-bib-0037){ref-type="ref"}          5                           Explant              ...                    12
  S38      27            Roberts et al, 2014[38](#jah34071-bib-0038){ref-type="ref"}          27                          Explant              ...                    17
  S39      28            Armstrong et al, 2015[39](#jah34071-bib-0039){ref-type="ref"}        1                           Explant              ...                    17
  S40      28            Armstrong et al, 2015[39](#jah34071-bib-0039){ref-type="ref"}        3                           Explant              ...                    17
  S41      29            Jeudy et al, 2015[40](#jah34071-bib-0040){ref-type="ref"}            2                           Autopsy              Sudden cardiac death   6
  S42      29            Jeudy et al, 2015[40](#jah34071-bib-0040){ref-type="ref"}            3                           Explant              ...                    6
  S43      29            Jeudy et al, 2015[40](#jah34071-bib-0040){ref-type="ref"}            4                           Explant              ...                    6
  S44      30            Kajimoto et al, 2015[41](#jah34071-bib-0041){ref-type="ref"}         2                           Autopsy              Hemorrhagic shock      17
  S45      31            Vasaturo et al, 2015[42](#jah34071-bib-0042){ref-type="ref"}         1                           Autopsy              Toxic shock syndrome   16
  S46      32            Di Gesaro et al, 2016[43](#jah34071-bib-0043){ref-type="ref"}        2                           Explant              ...                    17
  S47      33            Roberts et al, 2018[44](#jah34071-bib-0044){ref-type="ref"}          2                           Explant              ...                    6
  S48      33            Roberts et al, 2018[44](#jah34071-bib-0044){ref-type="ref"}          2                           Explant              ...                    6
  S49      33            Roberts et al, 2018[44](#jah34071-bib-0044){ref-type="ref"}          2                           Explant              ...                    6

LV indicates left ventricular.

![Illustrated examples of 5 gross pathological images from the study, demonstrating frequent features of myocardial involvement in cardiac sarcoidosis, are shown. **A**, Image is reprinted from Antecol and Roberts[17](#jah34071-bib-0017){ref-type="ref"} with permission. Copyright © 1990, Elsevier. **B**, Image is reprinted from Tavora et al[29](#jah34071-bib-0029){ref-type="ref"} with permission. Copyright © 2009, Elsevier. **C**, Image is reprinted from Armstrong et al[39](#jah34071-bib-0039){ref-type="ref"} with permission. Copyright © 2013, Wolters Kluwer Health, Inc. **D**, Image is reprinted from Roberts et al[44](#jah34071-bib-0044){ref-type="ref"} with permission. Copyright © 2018, American Medical Association. **E**, Image is reprinted from Morikawa et al[24](#jah34071-bib-0024){ref-type="ref"} with permission. Copyright © 2008, Elsevier. RV indicates right ventricular.](JAH3-8-e011253-g002){#jah34071-fig-0002}

Prevalence of Features of Myocardial Involvement {#jah34071-sec-0015}
------------------------------------------------

### Location of involvement within the LV wall {#jah34071-sec-0016}

Within the LV wall, the involvement was subepicardial in 98% of cases, with significantly lower midmyocardial (65.3%), subendocardial (53.1%), or transmural (63.3%) involvement (*P*\<0.05 for all) (Tables [2](#jah34071-tbl-0002){ref-type="table"} and [3](#jah34071-tbl-0003){ref-type="table"}).

###### 

Features of Myocardial Involvement in Cardiac Sarcoidosis on Gross Pathological Images

  Figure   Subepicardial LV Involvement   Midmyocardial LV Involvement   Subendocardial LV Involvement   Transmural LV Involvement   Multifocal LV Involvement   Septal LV Involvement   Lateral LV Involvement   Anterior LV Involvement   Inferior LV Involvement   Basal LV Involvement   Mid‐LV Involvement   Apical LV Involvement   RV Free Wall
  -------- ------------------------------ ------------------------------ ------------------------------- --------------------------- --------------------------- ----------------------- ------------------------ ------------------------- ------------------------- ---------------------- -------------------- ----------------------- --------------
  S1       Yes                            Yes                            Yes                             No                          Yes                         Yes                     Yes                      ...                       ...                       Yes                    Yes                  Yes                     ...
  S2       Yes                            No                             Yes                             Yes                         Yes                         Yes                     No                       ...                       ...                       Yes                    Yes                  Yes                     Yes
  S3       Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      ...                       ...                       Yes                    Yes                  Yes                     ...
  S4       Yes                            Yes                            No                              Yes                         Yes                         Yes                     No                       ...                       ...                       Yes                    Yes                  No                      No
  S5       Yes                            No                             Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       ...                    Yes                  ...                     Yes
  S6       Yes                            Yes                            No                              No                          Yes                         Yes                     No                       Yes                       Yes                       ...                    Yes                  ...                     Yes
  S7       Yes                            Yes                            No                              Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  ...                     Yes
  S8       Yes                            No                             Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S9       Yes                            Yes                            No                              No                          Yes                         Yes                     Yes                      ...                       ...                       Yes                    Yes                  Yes                     Yes
  S10      Yes                            No                             Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  No                      Yes
  S11      Yes                            No                             Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       No                        Yes                    Yes                  Yes                     Yes
  S12      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      ...                       ...                       Yes                    Yes                  Yes                     Yes
  S13      Yes                            No                             No                              No                          Yes                         Yes                     No                       No                        Yes                       Yes                    ...                  ...                     Yes
  S14      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    ...                  ...                     ...
  S15      Yes                            Yes                            No                              Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    ...                  ...                     Yes
  S16      Yes                            Yes                            No                              Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    ...                  ...                     Yes
  S17      Yes                            No                             Yes                             No                          Yes                         Yes                     Yes                      ...                       ...                       Yes                    Yes                  No                      ...
  S18      Yes                            Yes                            No                              No                          Yes                         Yes                     Yes                      No                        Yes                       Yes                    Yes                  Yes                     Yes
  S19      Yes                            Yes                            No                              Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S20      Yes                            Yes                            No                              No                          Yes                         Yes                     No                       No                        Yes                       Yes                    Yes                  ...                     Yes
  S21      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S22      No                             No                             No                              Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    ...                  ...                     No
  S23      Yes                            Yes                            Yes                             No                          Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S24      Yes                            No                             No                              No                          No                          Yes                     No                       No                        No                        ...                    Yes                  ...                     Yes
  S25      Yes                            No                             No                              Yes                         No                          Yes                     No                       No                        Yes                       ...                    Yes                  ...                     Yes
  S26      Yes                            Yes                            No                              Yes                         Yes                         Yes                     Yes                      ...                       ...                       Yes                    Yes                  Yes                     Yes
  S27      Yes                            Yes                            No                              Yes                         Yes                         Yes                     No                       ...                       ...                       Yes                    Yes                  No                      Yes
  S28      Yes                            Yes                            No                              No                          Yes                         Yes                     No                       Yes                       No                        ...                    Yes                  ...                     No
  S29      Yes                            No                             Yes                             Yes                         Yes                         Yes                     No                       Yes                       Yes                       ...                    Yes                  ...                     ...
  S30      Yes                            No                             No                              No                          Yes                         Yes                     Yes                      Yes                       No                        Yes                    ...                  ...                     Yes
  S31      Yes                            Yes                            No                              No                          Yes                         Yes                     No                       Yes                       Yes                       Yes                    ...                  ...                     Yes
  S32      Yes                            Yes                            No                              No                          Yes                         Yes                     Yes                      No                        No                        ...                    Yes                  ...                     No
  S33      Yes                            Yes                            Yes                             Yes                         Yes                         No                      Yes                      No                        Yes                       Yes                    Yes                  Yes                     Yes
  S34      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S35      Yes                            Yes                            Yes                             No                          Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S36      Yes                            Yes                            Yes                             No                          Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S37      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  ...                     Yes
  S38      Yes                            Yes                            Yes                             No                          Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S39      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S40      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S41      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    ...                  ...                     Yes
  S42      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      No                        Yes                       ...                    Yes                  ...                     Yes
  S43      Yes                            No                             No                              No                          No                          Yes                     No                       Yes                       No                        ...                    Yes                  ...                     ...
  S44      Yes                            No                             No                              Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  Yes                     Yes
  S45      Yes                            No                             Yes                             Yes                         Yes                         Yes                     No                       No                        No                        No                     Yes                  Yes                     Yes
  S46      Yes                            No                             No                              Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    Yes                  No                      Yes
  S47      Yes                            No                             No                              Yes                         Yes                         Yes                     No                       No                        Yes                       Yes                    ...                  ...                     Yes
  S48      Yes                            Yes                            Yes                             Yes                         Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    ...                  ...                     Yes
  S49      Yes                            Yes                            Yes                             No                          Yes                         Yes                     Yes                      Yes                       Yes                       Yes                    ...                  ...                     Yes

LV indicates left ventricular; RV, right ventricular.

###### 

Prevalence of Features of Myocardial Involvement in Cardiac Sarcoidosis

  Feature of Myocardial Involvement       Prevalence, No./Total (%)
  --------------------------------------- ---------------------------
  LV subepicardial involvement (any)      48/49 (98.0)
  LV midmyocardial involvement (any)      32/49 (65.3)
  LV subendocardial involvement (any)     26/49 (53.1)
  LV transmural involvement (any)         31/49 (63.3)
  LV multifocal involvement               46/49 (93.9)
  Septal segment involvement (any)        48/49 (98.0)
  LV lateral segment involvement (any)    35/49 (71.4)
  LV anterior segment involvement (any)   30/40 (75.0)
  LV inferior segment involvement (any)   33/40 (82.5)
  Basal LV involvement (any)              39/40 (97.5)
  Mid‐LV involvement (any)                38/38 (100.0)
  Apical LV involvement (any)             21/26 (80.8)
  RV free wall involvement (any)          39/43 (90.7)

LV indicates left ventricular; RV, right ventricular.

### Focality within the LV {#jah34071-sec-0017}

Multifocal LV involvement was significantly more common than unifocal involvement (93.9% versus 6.1%; *P*\<0.05).

### LV segments involved {#jah34071-sec-0018}

The septal segments were involved in 98% of cases, with significantly lower involvement of the anterior (75.0%), lateral (71.4%), and inferior (82.5%) segments (*P*\<0.05 for all).

### LV levels involved {#jah34071-sec-0019}

The basal and mid LV were almost always involved (97.5% and 100%, respectively), and the apical LV was less often involved when compared with either basal or mid LV (80.8%; *P*\<0.05 for both comparisons). However, the difference was not significant when comparisons were made only using the 26 patients who had pathological images of all LV levels.

### Involvement of the RV free wall {#jah34071-sec-0020}

The RV free wall was involved in 90.7% of cases.

Rare Features of Myocardial Involvement {#jah34071-sec-0021}
---------------------------------------

On the basis of the above, we identified a list of rare features (Table [4](#jah34071-tbl-0004){ref-type="table"}). These features had a prevalence of \<6%, and many were never present. There were no patients without gross LV myocardial involvement. LV midmyocardial or subendocardial involvement without subepicardial involvement was never present. LV transmural involvement without separate subepicardial involvement was present in only 1 patient (2.0%). Unifocal involvement was present in only 6.1% of patients. Absence of septal involvement was noted in only 1 patient (2.0%). In terms of the levels of involvement, isolated involvement of only one LV level was seen in only 1 patient (2.0%) for the basal level and 0 patients for the mid and apical levels.

###### 

Rare Features of Myocardial Involvement in Cardiac Sarcoidosis

  Feature of Myocardial Involvement                                      Prevalence, No./Total (%)
  ---------------------------------------------------------------------- ---------------------------------------------------
  No gross LV involvement                                                0/49 (0.0)
  No LV subepicardial involvement                                        1/49 (2.0)
  LV midmyocardial involvement without subepicardial involvement         0/49 (0.0)
  LV subendocardial involvement without subepicardial involvement        0/49 (0.0)
  LV transmural involvement without separate subepicardial involvement   1/49 (2.0)
  LV unifocal involvement                                                3/49 (6.1)
  No septal wall involvement                                             1/49 (2.0)
  LV lateral wall involvement without septal wall involvement            1/49 (2.0)
  No LV basal involvement                                                1/26 (3.8)[a](#jah34071-note-0005){ref-type="fn"}
  No LV mid involvement                                                  0/26 (0.0)[a](#jah34071-note-0005){ref-type="fn"}
  Apical LV involvement without basal or mid LV involvement              0/26 (0.0)[a](#jah34071-note-0005){ref-type="fn"}

LV indicates left ventricular.

A total of 26 patients had images of the basal, mid, and apical LV.

Discussion {#jah34071-sec-0022}
==========

In this systematic review and meta‐analysis of gross pathological images of hearts from patients with histologically diagnosed cardiac sarcoidosis who underwent either autopsy or heart transplantation for cardiac sarcoidosis, we identified frequent and rare features of myocardial involvement. LV subepicardial, LV multifocal, septal, and RV free wall involvement were frequent (present in \>90% of patients) features. On the other hand, lack of gross LV myocardial, isolated LV midmyocardial, or isolated LV subendocardial involvement was never present. Similarly, isolated LV transmural involvement, absence of septal involvement, and isolated involvement of only one LV level were rare (present in 2% of patients) features.

One of the key strengths of our data is that they are derived only from patients with histologically diagnosed cardiac sarcoidosis. The contemporary understanding of myocardial involvement in cardiac sarcoidosis, in which no specific patterns are believed to be pathognomonic for cardiac sarcoidosis, is largely based on LGE CMR data,[7](#jah34071-bib-0007){ref-type="ref"} which include patients with clinical but not histologically diagnosed cardiac sarcoidosis. In these studies, a clinical diagnosis of cardiac sarcoidosis is reached after excluding other explanations for the LGE,[3](#jah34071-bib-0003){ref-type="ref"} which may not always be accurate. For instance, coronary artery disease as the cause for subendocardial LGE in patients with suspected cardiac sarcoidosis is typically excluded by the absence of obstructive coronary artery disease on coronary angiography.[7](#jah34071-bib-0007){ref-type="ref"} However, this does not exclude the possibility of myocardial infarction with nonobstructive coronary arteries.[45](#jah34071-bib-0045){ref-type="ref"}, [46](#jah34071-bib-0046){ref-type="ref"}

Our data demonstrate that there are characteristic features of myocardial involvement in cardiac sarcoidosis. These features could be used to identify patients with cardiac sarcoidosis using LGE CMR and ^18^F‐FDG positron emission tomography, particularly those in whom cardiac sarcoidosis was not suspected before the imaging study. More important, these data imply that patients with LGE or ^18^F‐FDG uptake in patterns that were never or rarely present in this systematic review could have an alternate explanation for the imaging findings. For instance, isolated subendocardial LGE may represent a myocardial infarction, and in the absence of coronary artery disease, it may still represent myocardial infarction with nonobstructive coronary arteries, rather than cardiac sarcoidosis. Similarly, ^18^F‐FDG uptake isolated to the lateral wall may represent inadequate suppression of physiological uptake rather than true cardiac sarcoidosis.[47](#jah34071-bib-0047){ref-type="ref"}

Limitations {#jah34071-sec-0023}
-----------

Our systematic review and meta‐analysis is based on the published pathological literature, which introduces bias. Only a third of cases had 16 or 17 segments included in the gross pathological images, which raises the possibility that some of the features of myocardial involvement could have been missed. Cases included in the publications represent the most impressive cases and may not be representative of the entire spectrum of pathologically identified myocardial involvement in cardiac sarcoidosis. Similarly, our systematic review focuses on end‐stage cardiac sarcoidosis (ie, those who either died of cardiac sarcoidosis or underwent heart transplantation because of it). Thus, it could be argued that our data do not include features of early myocardial involvement in cardiac sarcoidosis. However, our cases represent the adverse outcomes that we aim to avoid in patients with suspected cardiac sarcoidosis (ie, cardiac death and heart transplantation). Therefore, our data may carry prognostic implications. Studies are ongoing using these patterns of myocardial involvement on LGE CMR or ^18^F‐FDG to risk stratify patients with suspected cardiac sarcoidosis.

Conclusions {#jah34071-sec-0024}
===========

Myocardial involvement in end‐stage cardiac sarcoidosis involves frequent (LV subepicardial, LV multifocal, septal, and RV free wall involvement) and rare (lack of gross LV myocardial involvement, isolated LV midmyocardial involvement, isolated LV subendocardial involvement, isolated LV transmural involvement, absence of septal involvement, or isolated involvement of only one LV level) features. These patterns could be used to improve diagnosis and prognostication of suspected cardiac sarcoidosis with noninvasive imaging modalities, such as LGE CMR and ^18^F‐FDG positron emission tomography.
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